Farnum Rhonda

Track

Insider profile

Performance

Overall performance
2.6
Performance over holding periods
2.6
30 days 90 days 120 days
Average return -5% 8.2% 15.1%
Success rate 33% 68% 82%
Transactions
17 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Farnum Rhonda's trades of Theravance Biopharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-17 2026-06-15
S Sale
33,248 +25.3%
36.00
US$4,587,197 		33,248 +25.3% 36.00 US$4,587,197
2026-06-17 2026-06-15
S Sale
74,472 +49.4%
416.10
US$474,384 		74,472 +49.4% 416.10 US$474,384
2026-06-17 2026-06-15
S Sale
5,326 +0.1%
63.13
US$970,005 		5,326 +0.1% 63.13 US$970,005
2026-06-15 2026-06-15
PrS Proposed sale
13,314
16.39
US$218,167 		13,314 16.39 US$218,167
2026-03-18 2026-03-16
S Sale
7,766 -3.2%
13.92
US$108,073 		7,766 -3.2% 13.92 US$108,073
2026-03-18 2026-03-16
S Sale
15,534 -6.1%
14.00
US$217,476 		15,534 -6.1% 14.00 US$217,476
2026-03-18 2026-03-16
S Sale
7,767 -2.9%
13.92
US$108,088 		7,767 -2.9% 13.92 US$108,088
2026-03-16 2026-03-16
PrS Proposed sale
31,067
13.96
US$433,637 		31,067 13.96 US$433,637
2025-12-05 2025-12-03
S Sale
15,534 -5.3%
18.75
US$291,252 		15,534 -5.3% 18.75 US$291,252
2025-12-05 2025-12-03
S Sale
7,766 -2.6%
18.75
US$145,619 		7,766 -2.6% 18.75 US$145,619
2025-12-05 2025-12-03
S Sale
7,767 -2.5%
18.75
US$145,630 		7,767 -2.5% 18.75 US$145,630
2025-12-03 2025-12-03
PrS Proposed sale
31,067
18.75
US$582,500 		31,067 18.75 US$582,500
2025-07-16 2025-07-14
S Sale
4,000 -1.2%
11.39
US$45,552 		4,000 -1.2% 11.39 US$45,552
2025-07-16 2025-07-14
S Sale
5,318 -1.6%
11.39
US$60,548 		5,318 -1.6% 11.39 US$60,548
2025-07-16 2025-07-14
S Sale
682 -0.2%
11.39
US$7,770 		682 -0.2% 11.39 US$7,770
2025-07-14 2025-07-14
PrS Proposed sale
10,000
11.39
US$113,869 		10,000 11.39 US$113,869
2025-06-04 2025-06-02
S Sale
24,000 -6.6%
11.00
US$264,000 		24,000 -6.6% 11.00 US$264,000
2025-06-02 2025-06-02
PrS Proposed sale
24,000
11.00
US$264,000 		24,000 11.00 US$264,000
2025-04-23 2025-04-21
S Sale
4,000 -1.1%
9.00
US$36,000 		4,000 -1.1% 9.00 US$36,000
2025-01-23 2025-01-21
S Sale
4,000 -1.3%
9.00
US$36,000 		4,000 -1.3% 9.00 US$36,000
2025-01-21 2025-01-21
PrS Proposed sale
4,000
9.00
US$36,000 		4,000 9.00 US$36,000
2024-11-13 2024-11-11
S Sale
4,000 -1.2%
9.00
US$36,000 		4,000 -1.2% 9.00 US$36,000
2024-07-12 2024-07-10
PlS Planned sale
4,000 -1.2%
9.00
US$36,000 		4,000 -1.2% 9.00 US$36,000
2024-02-22 2024-02-22
PlS Planned sale
1,254 -0.4%
8.71
US$10,922 		1,254 -0.4% 8.71 US$10,922
2023-11-22 2023-11-21
PlS Planned sale
1,378 -0.4%
10.29
US$14,180 		1,378 -0.4% 10.29 US$14,180
2023-08-24 2023-08-22
PlS Planned sale
1,807 -0.5%
9.47
US$17,112 		1,807 -0.5% 9.47 US$17,112
2023-06-12 2023-06-08
PlS Planned sale
1,790 -0.5%
11.13
US$19,923 		1,790 -0.5% 11.13 US$19,923
2023-06-08 2023-06-08
PrS Proposed sale
1,790
11.13
US$19,923 		1,790 11.13 US$19,923
2023-03-13 2023-03-09
S Sale
4,000 -1.1%
10.20
US$40,800 		4,000 -1.1% 10.20 US$40,800
2022-05-24 2022-05-23
PlS Planned sale
1,081 -0.3%
8.93
US$9,653 		1,081 -0.3% 8.93 US$9,653
2022-03-02 2022-02-28
PlS Planned sale
2,356 -0.7%
10.16
US$23,947 		2,356 -0.7% 10.16 US$23,947